Clinical Trial Update: Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating the efficacy and safety of SCT650C for moderate to severe hidradenitis suppurativa, with the study status not yet rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• SCT650C

Snippet

Sponsor: Sinocelltech Ltd. | Conditions: Hidradenitis Suppurativa (HS) | Phase 2 | Status: NOT_YET_RECRUITING